StonvexLoading…
StonvexStonvexStonvexCore line items from INSM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $305.96M | $606.42M | $342.58M | $200.24M |
Operating Income | $-153.32M | $-1.25B | $-927.02M | $-561.02M |
Net Income | $-163.56M | $-1.28B | $-948.29M | $-578.27M |
EPS (Diluted) | $-0.76 | $-6.42 | $-4.89 | $-3.12 |
Total Assets | $2.08B | $2.26B | $2.36B | $2.48B |
Total Liabilities | $1.37B | $1.53B | $1.42B | $1.23B |
Cash & Equivalents | $582.19M | $510.44M | $334.76M | $1.28B |
Free Cash Flow OCF − CapEx | $-226.22M | $-967.58M | $-703.39M | $-481.21M |
Shares Outstanding | 216.52M | 214.26M | 212.58M | 211.11M |